{"id":176297,"date":"2021-03-19T00:00:00","date_gmt":"2021-03-18T23:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/covid-19-arret-premature-du-bras-colchicine-de-letude-recovery-chez-des-patients-covid-19-hospitalises\/"},"modified":"2026-04-09T17:11:48","modified_gmt":"2026-04-09T15:11:48","slug":"covid-19-arret-premature-du-bras-colchicine-de-letude-recovery-chez-des-patients-covid-19-hospitalises","status":"publish","type":"post","link":"https:\/\/h.bcfi.be\/fr\/covid-19-arret-premature-du-bras-colchicine-de-letude-recovery-chez-des-patients-covid-19-hospitalises\/","title":{"rendered":"COVID-19: arr\u00eat pr\u00e9matur\u00e9 du bras colchicine de l&rsquo;\u00e9tude RECOVERY chez des patients COVID-19  hospitalis\u00e9s"},"content":{"rendered":"<p>Les <a href='https:\/\/www.recoverytrial.net\/news\/recovery-trial-closes-recruitment-to-colchicine-treatment-for-patients-hospitalised-with-covid-19'>investigateurs de l&#39;<strong>\u00e9tude RECOVERY<\/strong><\/a> ont annonc\u00e9 le 5 mars 2021 que le <strong>recrutement pour un traitement \u00e0 la colchicine de patients COVID-19 hospitalis\u00e9s a \u00e9t\u00e9 cl\u00f4tur\u00e9<\/strong>. Une analyse interm\u00e9diaire ne r\u00e9v\u00e9lait <strong>aucun b\u00e9n\u00e9fice<\/strong> de la colchicine sur le crit\u00e8re d\u2019\u00e9valuation primaire (\u00ab\u00a0mortalit\u00e9 apr\u00e8s 28 jours\u00a0\u00bb)&#x002C; et les investigateurs ne pr\u00e9voient pas de b\u00e9n\u00e9fice en cas de poursuite du recrutement. L&#39;\u00e9tude RECOVERY est une \u00e9tude randomis\u00e9e \u00e0 grande \u00e9chelle men\u00e9e aupr\u00e8s de patients COVID-19 hospitalis\u00e9s&#x002C; dans laquelle divers traitements sont compar\u00e9s aux \u00ab\u00a0soins habituels\u00a0\u00bb. Les investigateurs font savoir que les r\u00e9sultats d\u00e9finitifs seront publi\u00e9s d\u00e8s que possible.<br \/> \u00a0<br \/> En ce qui concerne le communiqu\u00e9 de presse tr\u00e8s m\u00e9diatis\u00e9 sur l&#39;<strong>\u00e9tude ColCORONA<\/strong>&#x002C; nous n\u2019avons rien de nouveau \u00e0 signaler. Il s&#39;agit d&#39;une \u00e9tude randomis\u00e9e \u00e9valuant l&#39;effet de la colchicine sur l\u2019apparition de complications graves chez des <strong>patients COVID-19 non hospitalis\u00e9s<\/strong> (voir notre <a href='https:\/\/www.cbip.be\/fr\/articles\/3556?folia=3549'>communiqu\u00e9 Bon \u00e0 savoir dans les Folia de mars 2021<\/a>). Cette \u00e9tude <strong>n&#39;a toujours pas \u00e9t\u00e9 examin\u00e9e par des pairs et n\u2019a toujours pas \u00e9t\u00e9 publi\u00e9e<\/strong>. Nous reviendrons sur cette \u00e9tude d\u00e8s que les r\u00e9sultats en seront publi\u00e9s.<br \/> \u00a0<br \/> Nous rappelons que la colchicine est un m\u00e9dicament \u00e0 <strong>marge th\u00e9rapeutique-toxique \u00e9troite<\/strong>. Elle est susceptible de provoquer des effets ind\u00e9sirables graves [voir les <a href='https:\/\/www.cbip.be\/fr\/articles\/3556?folia=3549'>Folia de mars 2021<\/a> et le <a href='https:\/\/www.cbip.be\/fr\/chapters\/10?frag=7146'>chapitre 9.3.1 du R\u00e9pertoire<\/a>].<br \/> \u00a0<br \/> <strong>Note: <\/strong>pour tous nos articles relatifs aux m\u00e9dicaments dans la COVID-19: voir les <a href='https:\/\/www.cbip.be\/fr\/gows\/3334'>Actualit\u00e9s COVID-19 <\/a>\u00a0sur notre site Web.<br \/> \u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les investigateurs de l&#39;\u00e9tude RECOVERY ont annonc\u00e9 le 5 mars  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,31],"tags":[48,20213,20224,20226],"class_list":["post-176297","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2021-fr","tag-actualites-covid-19","tag-import_tags","tag-import_tags-nl","tag-covid-19-update"],"_links":{"self":[{"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/posts\/176297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/comments?post=176297"}],"version-history":[{"count":1,"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/posts\/176297\/revisions"}],"predecessor-version":[{"id":178876,"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/posts\/176297\/revisions\/178876"}],"wp:attachment":[{"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/media?parent=176297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/categories?post=176297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h.bcfi.be\/fr\/wp-json\/wp\/v2\/tags?post=176297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}